Dear Colleague,

We are pleased to formally inform you about a digital conference arranged by AstraZeneca in conjunction with the educational meeting arranged by the Nordic CLL Study Group (NCLLSG) on the 13^th of April. AstraZeneca AS is holding this event as a sponsor of the NCLLSG Educational Meeting and will take place on the 14^th of April 2021 from 15.00-17.00 with the topic

Personalized treatment Approach to Chronic Lymphocytic Leukemia: MDT discussions.

A panel with an international moderator and physicians from all four Nordic countries will

have multidisciplinary team discussions on management of treatment naïve and relapse/refractory CLL in the Nordic countries.

Health care professional from Nordic countries are welcome to join this meeting.

Venue

The meeting will take place as a digital conference.  Invitations including program details and link for registration will be sent out from AstraZeneca separately to the participants in the NCLLSG Educational Meeting.

Preliminary program

Personalized treatment approach to Chronic Lymphocytic Leukemia: MDT discussions and polls

15:00-15:00	Welcome
15:15-16:45	Multidisciplinary team discussions on making therapeutic choices in management of treatment naïve and relapse/refractory CLL International moderator: Vishal Jayakar MD, MRCP, FRCPath, Consultant Haemato-Oncologist - Kingston Hospital Panel: Dr Carsten Niemann, Rigshospitalet, Copenhagen University Hospital, Denmark Dr Christian Brieghel, Sjællands Universitetshospital, Roskilde - Region Sjælland, Denmark Dr Hoa Thi Tuyet Tran, Akershus University Hospital, Norway Dr Geir E Tjønnfjord, Oslo University Hospital, Norway Dr Mattias Mattsson, Uppsala University, Sweden Dr Richard Rosenquist Brandell, Karolinska University Hospital, Sweden Dr Juha Ranti, Turku University Hospital, Finland
16:45-17:00	Q&A and closing remarks

Please contact amarah.dar@astrazeneca.com for questions regarding the meeting.